Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MVIRB:SS

83.7500 SEK 3.0000 3.46%

As of 05:48:47 ET on 03/03/2015.

Company Profile for Medivir AB (MVIRB)

Medivir AB is a medical research company. The Company develops new drugs and pharmaceutical compounds based on proteases and polymerases as target enzymes. Medivir focuses on infectious and immunological diseases including projects against HIV, jaundice, shingles, multiple sclerosis, and rheumatoid arthritis. The Company is located in Huddinge, Sweden and Cambridge, United Kingdom.

Contact Information

Medivir AB

Lunastigen 7
Huddinge, 141 44
Sweden
Phone: 46-8-546-831-00
Fax: 46-8-546-831-99

Key Executives for Medivir AB (MVIRB)

Niklas PragerPresident/CEOOla BurmarkCFO
Richard BethellExec VP:Discovery ResearchHenrik KrookExec VP:Commercial
Charlotte EdeniusExec VP:Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil